Works matching IS 13520504 AND DT 2015 AND VI 22 AND IP 9

Results: 10

Clonal expansion of hepatocytes with a selective advantage occurs during all stages of chronic hepatitis B virus infection.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 737, doi. 10.1111/jvh.12380

By:

Tu, T.;
Mason, W. S.;
Clouston, A. D.;
Shackel, N. A.;
McCaughan, G. W.;
Yeh, M. M.;
Schiff, E. R.;
Ruszkiewicz, A. R.;
Chen, J. W.;
Harley, H. A. J.;
Stroeher, U. H.;
Jilbert, A. R.

Publication type:

Article

Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 727, doi. 10.1111/jvh.12381

By:

Goldberg, D. S.;
Valderrama, A.;
Kamalakar, R.;
Sansgiry, S. S.;
Babajanyan, S.;
Lewis, J. D.

Publication type:

Article

Successful treatment with telaprevir-based regimens for chronic hepatitis C results in significant improvements to serum markers of liver fibrosis.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 701, doi. 10.1111/jvh.12382

By:

Haseltine, E. L.;
Penney, M. S.;
George, S.;
Kieffer, T. L.

Publication type:

Article

Factors associated with hepatitis C virus RNA levels in early chronic infection: the InC<sup>3</sup> study.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 708, doi. 10.1111/jvh.12384

By:

Hajarizadeh, B.;
Grady, B.;
Page, K.;
Kim, A. Y.;
McGovern, B. H.;
Cox, A. L.;
Rice, T. M.;
Sacks‐Davis, R.;
Bruneau, J.;
Morris, M.;
Amin, J.;
Schinkel, J.;
Applegate, T.;
Maher, L.;
Hellard, M.;
Lloyd, A. R.;
Prins, M.;
Geskus, R. B.;
Dore, G. J.;
Grebely, J.

Publication type:

Article

Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 718, doi. 10.1111/jvh.12387

By:

Désiré, N.;
Ngo, Y.;
Franetich, J.‐F.;
Dembele, L.;
Mazier, D.;
Vaillant, J.‐C.;
Poynard, T.;
Thibault, V.

Publication type:

Article

Hepatic involvement in congenital cytomegalovirus infection - infrequent yet significant.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 763, doi. 10.1111/jvh.12374

By:

Bilavsky, E.;
Schwarz, M.;
Bar‐Sever, Z.;
Pardo, J.;
Amir, J.

Publication type:

Article

Virologic response and haematologic toxicity of boceprevir- and telaprevir-containing regimens in actual clinical settings.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 691, doi. 10.1111/jvh.12375

By:

Butt, A. A.;
Yan, P.;
Shaikh, O. S.;
Freiberg, M. S.;
Lo Re, V.;
Justice, A. C.;
Sherman, K. E.

Publication type:

Article

Efficacy and safety of telbivudine treatment: an open-label, prospective study in pregnant women for the prevention of perinatal transmission of hepatitis B virus infection.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 754, doi. 10.1111/jvh.12379

By:

Han, G.‐R.;
Jiang, H.‐X.;
Yue, X.;
Ding, Y.;
Wang, C.‐M.;
Wang, G.‐J.;
Yang, Y.‐F.

Publication type:

Article

Issue Information.

Published in:: Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. i, doi. 10.1111/jvh.12326
Publication type:: Article

Therapy for hepatitis C genotype 3: moving forward.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 9, p. 683, doi. 10.1111/jvh.12419

By:

Buti, M.;
Llaneras, J.;
Riveiro‐Barciela, M.;
Esteban, R.

Publication type:

Article